Son V. Pham
Carl T. Hayden Veterans Affairs Medical Center · 30 works · 1,122 citations · h-index 11
Top works
- Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2
- Hypomagnesemia in Patients with Type 2 Diabetes
- Hypomagnesemia: a clinical perspective
- 2017 update on pain management in patients with chronic kidney disease
- The link between lower serum magnesium and kidney function in patients with diabetes mellitus Type 2 deserves a closer look
- Acute Coronary Syndrome in Patients with Diabetes Mellitus: Perspectives of an Interventional Cardiologist
- Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial
- Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?
- COMBINED SYSTEMIC THROMBOLYSIS AND CATHETER-DIRECTED THROMBECTOMY FOR A MASSIVE PROVOKED PULMONARY EMBOLISM WITH CLOT-IN-TRANSIT
- Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
- EMPA-REG OUTCOME: The Cardiologist's Point of View
- Cardiac Manifestations of Congenital Generalized Lipodystrophy
- Acute Life-Threatening Contrast Induced Thrombocytopenia Following Diagnostic Coronary Angiography: A Case Report and Literature Review
- EMPA-REG OUTCOME: The Cardiologist's Point of View
- Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
- The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes
- Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes
- Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes
- Glycemic Control in Type 2 Diabetes: The Tighter the Better?
- Myocardial considerations in type 2 diabetes: 2018